I. Tigchelaar et al., PLATELET-FUNCTION ANALYSIS AFTER IN-VITRO TREATMENT WITH HEMOSTASIS-AFFECTING COMPONENTS, Seminars in thrombosis and hemostasis, 21, 1995, pp. 71-76
An overall platelet function test in whole blood, which simulates cond
itions under arterial pressure, is useful in measuring the effect of p
olymer materials on blood hemostatic function. We performed biocompati
bility tests with materials or plasma substitutes by interaction of bl
ood from healthy volunteers and then subjected these blood samples to
platelet function analysis (Thrombostat). We tested also the capacity
of locally applied hemostatic agents for bleeding control by direct ap
plication of these agents onto the Thrombostat measuring cell. The bio
compatibility tests with materials exposed to blood appeared very disc
riminating between compatible and noncompatible materials. The hemosta
tic capacity of blood exposed to noncompatible materials (assessed by
binding of active thrombin) reduced markedly after one hour incubation
of the material. The plasma substitutes did not affect hemostasis sig
nificantly. However, a blood dilution of 40%, as in cardiopulmonary by
pass, increased the time required for closure of the measuring cell by
a platelet plug exponentially. Local hemostatic agents could be selec
ted according to their capacity to enhance platelet plug formation. In
addition, ADP mixed with the hemostatic agent was most effective in i
mproving capacity. We conclude that platelet function analysis contrib
utes importantly to screening of materials and plasma substitutes with
regard to their interaction with primary hemostasis.